<?xml version="1.0" encoding="UTF-8"?>
<mods xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.1" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
  <titleInfo>
    <title>Accelerating the development of priority formulations in childhood cancer</title>
    <subTitle>target product profiles for paediatric formulations of cyclophosphamide, etoposide, mercaptopurine, methotrexate, procarbazine, temozolomide</subTitle>
  </titleInfo>
  <name type="corporate">
    <namePart>World Health Organization</namePart>
  </name>
  <typeOfResource>text</typeOfResource>
  <originInfo>
    <place>
      <placeTerm type="code" authority="marccountry">sz</placeTerm>
    </place>
    <place>
      <placeTerm type="text">Geneva</placeTerm>
    </place>
    <publisher>World Health Organization</publisher>
    <dateIssued>2025</dateIssued>
    <issuance>monographic</issuance>
  </originInfo>
  <language>
    <languageTerm authority="iso639-2b" type="code">eng</languageTerm>
  </language>
  <physicalDescription>
    <form authority="gmd">electronic resource</form>
    <extent>1 online resource (63 pages) : ill.</extent>
  </physicalDescription>
  <subject authority="lcsh">
    <topic>Drug development</topic>
  </subject>
  <subject authority="lcsh">
    <topic>Cancer in children</topic>
    <topic>Adjuvant treatment</topic>
  </subject>
  <subject authority="lcsh">
    <topic>Cancer in children</topic>
  </subject>
  <classification authority="lcc">RC271 A35 A23 2025eb</classification>
  <identifier type="isbn">9789240116092</identifier>
  <identifier type="uri">https://www.who.int/publications/i/item/9789240116092</identifier>
  <location>
    <url displayLabel="Free eBook from WHO">https://www.who.int/publications/i/item/9789240116092</url>
  </location>
  <recordInfo>
    <recordCreationDate encoding="marc">251029</recordCreationDate>
    <recordChangeDate encoding="iso8601">20260817161355.0</recordChangeDate>
  </recordInfo>
</mods>
